Project Number 5R21AG073787-02 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for ENGINEERED HUMAN MICROGLIA AS A CELL-BASED THERAPY FOR A-BETA PLAQUE REMOVAL Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) f. Inflammation Researcher and Organization Principal Investigator BLURTON-JONES, MATHEW MARK Principal Investigator First Name MATHEW MARK Principal Investigator Last Name BLURTON-JONES Awardee Organization UNIVERSITY OF CALIFORNIA IRVINE Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PA-20-195: NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) FY Overall Cost $192,422 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
